Heel pain on the first steps of the morning — that sharp, stabbing sensation that makes you hobble to the bathroom before your foot "warms up" — is one of the most common musculoskeletal presentations in clinical practice. It affects approximately 10% of the population at some point and accounts for around 15% of all foot complaints presenting to healthcare practitioners. Most people are told they have plantar fasciitis. Most of them are then told to rest, ice it, and maybe get a cortisone injection.
The problem is not just that these responses are often ineffective. The problem starts earlier — with the name. Plantar fasciitis describes the wrong disease. What is actually happening in the tissue is fundamentally different from inflammation, and that difference changes everything about what an effective treatment should look like.
Getting the Terminology Right: Fasciitis, Fasciosis, or Fasciopathy?
The suffix -itis means inflammation — a biological process characterised by the influx of inflammatory cells (neutrophils, macrophages, prostaglandins) to a site of tissue injury. For acute presentations, a degree of reactive inflammation may be present in the first days to weeks. But the overwhelming majority of people who present with plantar heel pain are not in the acute phase. They have been symptomatic for months. And in those cases, the histology tells a very different story.
Lemont, Ammirati, and Usen published a landmark histological study in the Journal of the American Podiatric Medical Association in 2003, examining tissue samples from surgical resections of chronically symptomatic plantar fascia. Their findings were unambiguous: the specimens showed myxoid degeneration, collagen necrosis, chondroid metaplasia, and vascular hyperplasia — with a conspicuous absence of inflammatory cells. The authors concluded that the term "plantar fasciitis" was a misnomer, and proposed "plantar fasciosis" — meaning a degenerative process, not an inflammatory one — as more accurate.1
Contemporary clinical literature now more commonly uses the term plantar fasciopathy, aligning it with the broader tendinopathy framework established by Cook, Purdam, Malliaras, and others. This terminology reflects that the pathological process — collagen disorganisation, failed healing response, neovascularisation — is biologically analogous to what occurs in tendinopathy, regardless of whether the structure is technically a tendon or a fascial band. The treatment principles that follow from this are identical: progressive mechanical loading to drive remodelling, not anti-inflammatory management.
What the Plantar Fascia Actually Does: The Windlass Mechanism
To understand why plantar fasciopathy develops and why certain treatments work, you need to understand the plantar fascia's functional role — and its central place in the windlass mechanism of the foot.
The plantar fascia is a dense band of fibrous connective tissue originating from the medial process of the calcaneal tuberosity — the heel bone — and extending forward in three bands to insert at the base of each proximal phalanx and blend into the plantar plate of each metatarsophalangeal (MTP) joint. Its primary function is to act as a passive tension band along the plantar surface of the foot, supporting the medial longitudinal arch during weight-bearing.
The windlass mechanism describes what happens during the push-off phase of gait. As the heel rises and the toes extend, the great toe (and lesser toes) dorsiflex at the MTP joints. Because the plantar fascia inserts at these joints, dorsiflexion of the toes tensions the fascia — much like winding a rope around a capstan. This tensioning shortens the distance between the calcaneus and the MTP joints, which raises the medial longitudinal arch, externally rotates the tibia, and rigidifies the foot — converting it from a shock-absorbing mobile structure into a rigid lever for propulsion.2
This mechanism is load-critical. During the push-off phase of running, the plantar fascia experiences tensile loads estimated at approximately 1.3–2.9 times body weight per stride. Wearing, Smeathers, Urry, and colleagues, reviewing the pathomechanics in Sports Medicine, calculated that this generates peak stresses at the calcaneal insertion — the site of maximum vulnerability — sufficient to explain why pathological changes accumulate there under conditions of insufficient adaptation.3
The Deep Posterior Calf Compartment: The Overlooked Contributors
One of the most frequently missed aspects of plantar fasciopathy assessment is the role of the deep posterior compartment of the calf. Most practitioners focus on the gastrocnemius and soleus — and these are important — but three deeper muscles have direct mechanical relevance to plantar fascial load and are almost never addressed in standard treatment protocols.
Originates from the posterior fibula, travels through the tarsal tunnel posterior to the medial malleolus, and inserts into the distal phalanx of the great toe. When FHL is restricted — due to tightness or adhesion within its tendon sheath at the sustentaculum tali — it limits great toe dorsiflexion, directly impairing the windlass mechanism and increasing the compensatory load placed on the plantar fascia during push-off.
Originates from the posterior tibia, also passing through the tarsal tunnel before dividing to insert into the distal phalanges of the lesser toes. FDL restriction limits lesser toe dorsiflexion and alters the load distribution across the plantar fascia, concentrating stress medially at the calcaneal insertion.
The primary dynamic stabiliser of the medial longitudinal arch. It inserts broadly into the navicular tuberosity, medial cuneiform, and the bases of the 2nd–4th metatarsals. Weakness or dysfunction of tibialis posterior allows progressive arch collapse, increasing tensile load through the plantar fascia with every step. Tibialis posterior tendinopathy and plantar fasciopathy frequently co-exist.
Reduced ankle dorsiflexion ROM is one of the strongest independent risk factors for plantar fasciopathy. Riddle and colleagues' matched case-control study found that limited ankle dorsiflexion (defined as <0° with the knee extended) was associated with a 23.3-fold increased odds of plantar fasciitis — the single largest risk factor identified.4 A tight gastrocnemius-soleus complex restricts ankle movement, transferring load to the midfoot and plantar fascia.
Clinical implication: A complete assessment of plantar fasciopathy must include ankle dorsiflexion ROM (knee extended for gastrocnemius, knee flexed for soleus isolation), first MTPJ dorsiflexion ROM (windlass competence), tibialis posterior strength testing, and examination of the FHL and FDL through their tarsal tunnel course. Treating only the insertion site without addressing these upstream contributors is one of the primary reasons the condition recurs after initial improvement.
Foot Mechanics and Risk Factors: What the Evidence Shows
The relationship between foot posture and plantar fasciopathy is more nuanced than often presented. Both high-arched feet (pes cavus) and flat feet (pes planus) are associated with increased plantar fascial load — but through different mechanisms. A cavus foot is relatively rigid and absorbs less shock, transmitting greater tensile stress to the fascia. A planus foot is hypermobile and relies more heavily on dynamic muscular support — when that support is inadequate, the fascia is chronically overloaded through excessive pronation.
Irving, Cook, and Menz's systematic review in the Journal of Science and Medicine in Sport identified the strongest risk factors for chronic plantar heel pain: reduced ankle dorsiflexion (consistent with Riddle et al), elevated BMI, prolonged standing or walking on hard surfaces, and sudden increases in activity load. Running — particularly rapid increases in running volume — is a major precipitating factor, but plantar fasciopathy is equally common in sedentary individuals who spend extended hours on their feet, particularly on hard floors without adequate footwear.5
Dispelling the Myths
Plantar fasciitis is caused by inflammation. Anti-inflammatory treatments should be the first-line response.
Chronic plantar fasciopathy is a degenerative process — not inflammation. Biopsies show collagen necrosis and vascular proliferation, not inflammatory cells. NSAIDs and cortisone do not address the underlying pathology.1
A heel spur on X-ray is the cause of the pain and needs to be removed.
Heel spurs are found in approximately 50% of symptomatic patients — but also in 15–25% of asymptomatic people. They are the result of chronic tensile stress at the calcaneal insertion, not the cause of pain. Surgery to remove them does not reliably improve outcomes.6
Cortisone injection provides durable relief and is the right treatment if conservative measures haven't worked quickly.
Cortisone provides short-term pain relief (4–8 weeks) but has no advantage over other treatments at 6 months. Repeated injections are associated with plantar fascia rupture. Buchbinder's authoritative 2004 NEJM review does not recommend it as first-line care.6
Custom orthotics are significantly better than off-the-shelf insoles and are worth the expense as a primary treatment.
Landorf and colleagues' RCT found prefabricated and custom orthotics produced equivalent outcomes. Orthotics are an adjunct — they temporarily reduce tensile load at the insertion but do not drive the tissue remodelling that produces durable recovery.7
What the Evidence Actually Supports
The most robust evidence for plantar fasciopathy is now aligned with the tendinopathy model: the tissue requires progressive mechanical loading to remodel, and interventions that do not provide this are symptomatic management at best.
Rathleff and colleagues published a pivotal RCT in the Scandinavian Journal of Medicine & Science in Sports in 2015, comparing high-load progressive calf strengthening (single-leg calf raises on a stair, with a towel under the toes to pre-tension the plantar fascia via the windlass mechanism) against plantar fascia stretching alone. At 3-month follow-up, the high-load strengthening group showed significantly greater reductions in pain and improvements in function — and the differences were maintained at 12-month follow-up. The proposed mechanism is that high tensile load through the calcaneal insertion region drives collagen synthesis and the gradual reorganisation of disorganised fascial tissue.8
DiGiovanni and colleagues' 2003 RCT in the Journal of Bone and Joint Surgery established the tissue-specific plantar fascia stretch — pulling the toes into dorsiflexion to tension the fascia directly, rather than a generic calf stretch — as an effective component of management, producing superior outcomes to the Achilles stretch alone over 8 weeks.9 Night splints, which maintain the ankle in a neutral or slightly dorsiflexed position overnight (preventing the fascia from adopting its shortest resting length), have moderate evidence for symptom reduction, particularly for the post-static morning pain.6
Shockwave therapy has the strongest evidence of any physical modality for plantar fasciopathy — several systematic reviews and meta-analyses confirm statistically significant improvements in pain compared to sham treatment, particularly for chronic presentations that have not responded to 3 or more months of conservative management. Its mechanism involves mechanotransduction, local cellular stimulation of collagen synthesis, and neurogenic effects on local nociceptors.10
What a Comprehensive Assessment and Treatment Looks Like
Effective management of plantar fasciopathy is not simply a matter of giving someone calf raises and a stretch to do at home. It requires a systematic assessment: ankle dorsiflexion ROM (to quantify the gastrocnemius and soleus contribution), first MTPJ dorsiflexion (windlass competency), tibialis posterior strength, deep calf flexibility (FHL and FDL), load history (what has changed recently in standing, walking, or running), and footwear evaluation. From this, the primary contributors are identified and addressed — directly.
In practice, treatment typically includes soft tissue work to the deep posterior calf compartment (FHL and FDL in particular) to restore great toe dorsiflexion and windlass function; ankle and first MTP joint mobilisation where restriction is found; a progressive loading programme beginning with the tissue-specific plantar fascia stretch and progressing toward high-load calf raises; and education about load management — because a key driver in many cases is not weakness, but a sudden spike in activity that exceeded the tissue's current adaptive capacity. When the tissue's load tolerance is restored and the mechanical contributors are resolved, the condition resolves.
Heel pain that hasn't responded to stretching and rest?
A full lower limb assessment — including the deep calf compartment and windlass mechanism — identifies what's actually driving your plantar fasciopathy and builds a plan that targets the cause, not just the symptoms. Book at Kenmore or Jindalee.
- Lemont H, Ammirati KM, Usen N. Plantar fasciitis: a degenerative process (fasciosis) without inflammation. Journal of the American Podiatric Medical Association. 2003;93(3):234–237.
- Hicks JH. The mechanics of the foot. II. The plantar aponeurosis and the arch. Journal of Anatomy. 1954;88(1):25–30.
- Wearing SC, Smeathers JE, Urry SR, Hennig EM, Hills AP. The pathomechanics of plantar fasciitis. Sports Medicine. 2006;36(7):585–611.
- Riddle DL, Pulisic M, Pidcoe P, Johnson RE. Risk factors for plantar fasciitis: a matched case-control study. Journal of Bone and Joint Surgery (American). 2003;85(5):872–877.
- Irving DB, Cook JL, Menz HB. Factors associated with chronic plantar heel pain: a systematic review. Journal of Science and Medicine in Sport. 2006;9(1-2):11–22.
- Buchbinder R. Plantar fasciitis. New England Journal of Medicine. 2004;350(21):2159–2166.
- Landorf KB, Keenan AM, Herbert RD. Effectiveness of foot orthoses to treat plantar fasciitis: a randomized trial. Archives of Internal Medicine. 2006;166(12):1305–1310.
- Rathleff MS, Mølgaard CM, Fredberg U, et al. High-load strength training improves outcome in patients with plantar fasciitis: a randomized controlled trial with 12-month follow-up. Scandinavian Journal of Medicine & Science in Sports. 2015;25(3):e292–300.
- DiGiovanni BF, Nawoczenski DA, Lintal ME, et al. Tissue-specific plantar fascia-stretching exercise enhances outcomes in patients with chronic heel pain: a prospective, randomized study. Journal of Bone and Joint Surgery (American). 2003;85(7):1270–1277.
- Gollwitzer H, Saxena A, DiDomenico LA, et al. Clinically relevant effectiveness of focused extracorporeal shock wave therapy in the treatment of chronic plantar fasciitis: a randomized, controlled multicenter study. Journal of Bone and Joint Surgery (American). 2015;97(9):701–708.